Marker Therapeutics Stock Price History
| MRKR Stock | USD 1.70 0.22 11.46% |
Below is the normalized historical share price chart for Marker Therapeutics extending back to March 06, 1998. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Marker Therapeutics stands at 1.70, as last reported on the 19th of July, with the highest price reaching 1.89 and the lowest price hitting 1.63 during the day.
If you're considering investing in Marker Stock, it is important to understand the factors that can impact its price. Marker Therapeutics appears to be dangerous, given 3 months investment horizon. Marker Therapeutics has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11 % return per unit of risk over the last 3 months. By analyzing Marker Therapeutics' technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please exercise Marker Therapeutics' Downside Deviation of 4.79, mean deviation of 4.77, and Risk Adjusted Performance of 0.1272 to check out if our risk estimates are consistent with your expectations. At this time, Marker Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 07/19/2025, Common Stock Shares Outstanding is likely to grow to about 9.4 M, while Liabilities And Stockholders Equity is likely to drop slightly above 14 M. . At this time, Marker Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 07/19/2025, Price Earnings To Growth Ratio is likely to grow to 0.07, while Price Earnings Ratio is likely to drop (2.73). Marker Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of March 2014 | 200 Day MA 2.223 | 50 Day MA 1.409 | Beta 1.452 |
Sharpe Ratio = 0.1123
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MRKR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.04 actual daily | 63 63% of assets are less volatile |
Expected Return
| 0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Marker Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Marker Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.3273 | Enterprise Value Ebitda (0.22) | Price Sales 3.8139 | Shares Float 9.4 M | Wall Street Target Price 6 |
Marker Therapeutics Stock Price History Chart
There are several ways to analyze Marker Stock price data. The simplest method is using a basic Marker candlestick price chart, which shows Marker Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 17, 2025 | 1.92 |
| Lowest Price | May 21, 2025 | 1.1 |
Marker Therapeutics July 19, 2025 Stock Price Synopsis
Various analyses of Marker Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Marker Stock. It can be used to describe the percentage change in the price of Marker Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Marker Stock.| Marker Therapeutics Price Rate Of Daily Change | 0.89 | |
| Marker Therapeutics Price Action Indicator | (0.17) | |
| Marker Therapeutics Price Daily Balance Of Power | (0.85) | |
| Marker Therapeutics Accumulation Distribution | 243,636 |
Marker Therapeutics July 19, 2025 Stock Price Analysis
Marker Stock Price History Data
The price series of Marker Therapeutics for the period between Sun, Apr 20, 2025 and Sat, Jul 19, 2025 has a statistical range of 0.84 with a coefficient of variation of 17.09. The daily prices for the period are spread out with arithmetic mean of 1.39. The median price for the last 90 days is 1.42. The company underwent 1:10 stock split on 27th of January 2023. Marker Therapeutics issued dividends to stockholders on 2016-09-16.| Open | High | Low | Close | Volume | ||
07/18/2025 | 1.80 | 1.89 | 1.63 | 1.70 | 1,771,046 | |
| 07/17/2025 | 1.78 | 4.07 | 1.70 | 1.92 | 62,892,281 | |
07/16/2025 | 1.57 | 1.61 | 1.52 | 1.60 | 60,444 | |
07/15/2025 | 1.62 | 1.62 | 1.51 | 1.57 | 55,320 | |
07/14/2025 | 1.72 | 1.72 | 1.53 | 1.58 | 130,747 | |
07/11/2025 | 1.80 | 1.82 | 1.60 | 1.71 | 169,217 | |
07/10/2025 | 1.81 | 1.93 | 1.77 | 1.80 | 302,514 | |
07/09/2025 | 1.65 | 1.82 | 1.65 | 1.81 | 301,477 | |
07/08/2025 | 1.59 | 1.63 | 1.57 | 1.60 | 50,886 | |
07/07/2025 | 1.60 | 1.63 | 1.56 | 1.57 | 76,501 | |
07/03/2025 | 1.59 | 1.65 | 1.58 | 1.60 | 33,364 | |
07/02/2025 | 1.51 | 1.58 | 1.51 | 1.57 | 36,388 | |
07/01/2025 | 1.53 | 1.55 | 1.48 | 1.51 | 37,248 | |
06/30/2025 | 1.51 | 1.55 | 1.49 | 1.53 | 52,512 | |
06/27/2025 | 1.46 | 1.51 | 1.45 | 1.46 | 69,446 | |
06/26/2025 | 1.50 | 1.53 | 1.42 | 1.46 | 41,323 | |
06/25/2025 | 1.45 | 1.50 | 1.44 | 1.49 | 42,498 | |
06/24/2025 | 1.46 | 1.53 | 1.43 | 1.44 | 35,325 | |
06/23/2025 | 1.46 | 1.50 | 1.41 | 1.42 | 46,307 | |
06/20/2025 | 1.54 | 1.54 | 1.43 | 1.45 | 79,508 | |
06/18/2025 | 1.50 | 1.51 | 1.43 | 1.47 | 72,936 | |
| 06/17/2025 | 1.67 | 1.67 | 1.49 | 1.50 | 100,554 | |
06/16/2025 | 1.66 | 1.70 | 1.46 | 1.52 | 184,922 | |
06/13/2025 | 1.67 | 1.73 | 1.55 | 1.60 | 169,904 | |
06/12/2025 | 1.87 | 1.87 | 1.61 | 1.69 | 172,043 | |
| 06/11/2025 | 1.73 | 1.94 | 1.68 | 1.87 | 316,893 | |
06/10/2025 | 1.74 | 1.76 | 1.68 | 1.69 | 63,129 | |
06/09/2025 | 1.80 | 1.81 | 1.67 | 1.72 | 117,969 | |
06/06/2025 | 1.52 | 1.77 | 1.48 | 1.77 | 166,532 | |
06/05/2025 | 1.52 | 1.57 | 1.48 | 1.52 | 66,752 | |
06/04/2025 | 1.54 | 1.58 | 1.47 | 1.51 | 73,689 | |
06/03/2025 | 1.43 | 1.59 | 1.43 | 1.52 | 128,271 | |
06/02/2025 | 1.61 | 1.69 | 1.12 | 1.41 | 546,012 | |
05/30/2025 | 1.20 | 1.82 | 1.20 | 1.56 | 2,013,887 | |
| 05/29/2025 | 1.11 | 1.25 | 1.11 | 1.21 | 210,939 | |
05/28/2025 | 1.14 | 1.15 | 1.09 | 1.10 | 48,971 | |
05/27/2025 | 1.15 | 1.15 | 1.09 | 1.15 | 124,041 | |
05/23/2025 | 1.12 | 1.14 | 1.10 | 1.14 | 16,644 | |
05/22/2025 | 1.12 | 1.14 | 1.10 | 1.13 | 26,962 | |
05/21/2025 | 1.13 | 1.14 | 1.07 | 1.10 | 20,176 | |
| 05/20/2025 | 1.15 | 1.16 | 1.11 | 1.14 | 32,770 | |
| 05/19/2025 | 1.14 | 1.14 | 1.10 | 1.13 | 29,427 | |
05/16/2025 | 1.15 | 1.15 | 1.07 | 1.11 | 35,530 | |
05/15/2025 | 1.15 | 1.16 | 1.11 | 1.13 | 23,644 | |
05/14/2025 | 1.13 | 1.17 | 1.12 | 1.12 | 60,856 | |
05/13/2025 | 1.18 | 1.18 | 1.09 | 1.14 | 26,835 | |
05/12/2025 | 1.18 | 1.21 | 1.10 | 1.14 | 39,408 | |
05/09/2025 | 1.27 | 1.29 | 1.15 | 1.16 | 30,692 | |
05/08/2025 | 1.12 | 1.29 | 1.12 | 1.28 | 66,186 | |
05/07/2025 | 1.15 | 1.15 | 1.10 | 1.11 | 19,544 | |
05/06/2025 | 1.22 | 1.22 | 1.12 | 1.14 | 44,766 | |
05/05/2025 | 1.23 | 1.29 | 1.22 | 1.23 | 41,709 | |
05/02/2025 | 1.20 | 1.30 | 1.20 | 1.25 | 87,132 | |
05/01/2025 | 1.20 | 1.23 | 1.19 | 1.19 | 29,776 | |
| 04/30/2025 | 1.20 | 1.24 | 1.17 | 1.19 | 37,490 | |
04/29/2025 | 1.27 | 1.28 | 1.22 | 1.23 | 16,753 | |
04/28/2025 | 1.27 | 1.30 | 1.21 | 1.26 | 28,416 | |
04/25/2025 | 1.28 | 1.30 | 1.24 | 1.25 | 31,804 | |
04/24/2025 | 1.21 | 1.28 | 1.16 | 1.27 | 50,647 | |
04/23/2025 | 1.24 | 1.24 | 1.17 | 1.17 | 28,747 | |
04/22/2025 | 1.20 | 1.25 | 1.19 | 1.19 | 41,264 |
About Marker Therapeutics Stock history
Marker Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Marker is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Marker Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Marker Therapeutics stock prices may prove useful in developing a viable investing in Marker Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 9 M | 9.4 M | |
| Net Loss | -37.7 M | -39.6 M |
Marker Therapeutics Quarterly Net Working Capital |
|
Marker Therapeutics Stock Technical Analysis
Marker Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Marker Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Marker Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Marker Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Marker to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1272 | |||
| Jensen Alpha | 0.7094 | |||
| Total Risk Alpha | (0.10) | |||
| Sortino Ratio | 0.1556 | |||
| Treynor Ratio | 0.6845 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.